Newsbenzinga
Co-Diagnostics Reports Q2 2026 Results: Full Earnings Call Transcript
· Published
Article summary
On Thursday, Co-Diagnostics (NASDAQ:CODX) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call transcripts
An excerpt from the original article.
Comments —
Loading comments…